Encoded Library Technology Screening of Hepatitis C Virus NS4B Yields a Small-Molecule Compound Series with In Vitro Replicon Activity
Authors:
Open Access
- 1 June 2015
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 59 (6) , 3450-3459
Abstract
To identify novel antivirals to the hepatitis C virus (HCV) NS4B protein, we utilized encoded library technology (ELT), which enables purified proteins not amenable to standard biochemical screening methods to be tested against large combinatorial libraries in a short period of time. We tested NS4B against several DNA-encoded combinatorial libraries (DEL) and identified a single DEL feature that was subsequently progressed to off-DNA synthesis. The most active of the initial synthesized compounds had 50% inhibitory concentrations (IC 50 s) of 50 to 130 nM in a NS4B radioligand binding assay and 300 to 500 nM in an HCV replicon assay. Chemical optimization yielded compounds with potencies as low as 20 nM in an HCV genotype 1b replicon assay, 500 nM against genotype 1a, and 5 μM against genotype 2a. Through testing against other genotypes and genotype 2a-1b chimeric replicons and from resistance passage using the genotype 1b replicon, we confirmed that these compounds were acting on the proposed first transmembrane region of NS4B. A single sequence change (F98L) was identified as responsible for resistance, and it was thought to largely explain the relative lack of potency of this series against genotype 2a. Unlike other published series that appear to interact with this region, we did not observe sensitivity to amino acid substitutions at positions 94 and 105. The discovery of this novel compound series highlights ELT as a valuable approach for identifying direct-acting antivirals to nonenzymatic targets.Keywords
This publication has 42 references indexed in Scilit:
- Design and synthesis of spirocyclic compounds as HCV replication inhibitors by targeting viral NS4B proteinBioorganic & Medicinal Chemistry Letters, 2014
- Discovery of a Novel Class of Potent HCV NS4B Inhibitors: SAR Studies on Piperazinone DerivativesJournal of Medicinal Chemistry, 2014
- N-Terminal AH2 segment of protein NS4B from hepatitis C virus. Binding to and interaction with model biomembranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2013
- A hepatitis C virus NS4B inhibitor suppresses viral genome replication by disrupting NS4B’s dimerization/multimerization as well as its interaction with NS5AVirus Genes, 2013
- The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infectionNature Reviews Microbiology, 2013
- Hepatitis C Virus Proteins: From Structure to Function2013
- An Amphipathic α-Helix at the C Terminus of Hepatitis C Virus Nonstructural Protein 4B Mediates Membrane AssociationJournal of Virology, 2009
- A membranotropic region in the C-terminal domain of Hepatitis C virus protein NS4BBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Biochemical Characterization of Recombinant Hepatitis C Virus Nonstructural Protein 4B: Evidence for ATP/GTP Hydrolysis and Adenylate Kinase ActivityBiochemistry, 2009
- Palmitoylation and Polymerization of Hepatitis C Virus NS4B ProteinJournal of Virology, 2006